Atlas Trials

Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Clinical trial NCT00472225 · UNKNOWN

Trial details

NCT number
NCT00472225
Sponsor
The Korean Society of Hematopoietic Stem Cell Transplantation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Steroid-Refractory Chronic GVHD
Start date
2007-05-01
Primary completion
2008-05-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.